[EN] NOVEL NON-PSYCHOTROPIC CANNABINOIDS<br/>[FR] NOUVEAUX CANNABINOIDES NON PSYCHOTROPES
申请人:PHARMOS CORP
公开号:WO2001098289A1
公开(公告)日:2001-12-27
Novel non-psychotropic cannabinoids are disclosed and pharmaceutical compositions comprising these novel compounds are described for preventing neurotoxicity, neuroinflammation, immune or inflammatory disorders comprising as active ingredient the stereospecific (+) enantiomer, having (3S, 4S) configuration of Δ6 tetrahydrocannabinol type compounds. The compositions are particularly effective in alleviating and even preventing neurotoxicity due to acute injuries to the central nervous system, including mechanical trauma, compromised or reduced blood supply as may occur in cardiac arrest or stroke, or poisonings. They are also effective in the treatment of certain inflammatory disorders and chronic degenerative diseases characterized by neuronal loss and chronic pain including neuropathic pain.
本发明揭示了一种新型的非精神活性大麻素类化合物,并描述了包含这些新型化合物的制药组合物,其作为活性成分具有立体特异性的(+)对映体,具有(3S,4S) Δ6-四氢大麻酚类化合物的构型,用于预防神经毒性、神经炎症、免疫或炎症性疾病。这些组合物在缓解并甚至预防由于中枢神经系统急性损伤、机械创伤、心脏骤停或中风引起的血液供应受损或减少、中毒等神经毒性方面特别有效。它们还在治疗某些炎症性疾病和神经元丧失、慢性疼痛(包括神经病性疼痛)的慢性退行性疾病方面具有良好疗效。